Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;15(1):1-29.
doi: 10.11909/j.issn.1671-5411.2018.01.011.

2016 Chinese guidelines for the management of dyslipidemia in adults

2016 Chinese guidelines for the management of dyslipidemia in adults

Joint committee for guideline revision. J Geriatr Cardiol. 2018 Jan.
No abstract available

Keywords: Adults; Chinese guidelines; Dyslipidemia.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. The risk assessment flow chart of ASCVD.
*Including smoking, low HDL-C, and men ≥ 45 years of age or women ≥ 55 years of age. The risk assessment and treatment of patients with chronic kidney disease refer to the treatment of dyslipidemia in special populations. ASCVD: atherosclerotic cardiovascular disease; BMI: body mass index; CM: chylomicron; HDL-C: high-density lipoprotein cholesterol; IDL: intermediate-density lipoprotein; LDL-C: low-density lipoprotein cholesterol; TC: total cholesterol; TG: triglyceride; VLDL: very-low-density lipoprotein cholesterol.

References

    1. National Health and Family Planning Commission of the People's Republic of China . Report on conditions of nutrition and chronic diseases of Chinese residents (2015) Beijing, China: People's Health Publishing House; 2015.
    1. Moran A, Gu D, Zhao D, et al. Future cardiovascular disease in China: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes. 2010;3:243–252. - PMC - PubMed
    1. Ding W, Dong H, Mi J. [Prevalence of dyslipidemia in Chinese children and adolescents: A meta-analysis] Zhonghua Liu Xing Bing Xue Za Zhi. 2015;36:71–77. [Article in Chinese] - PubMed
    1. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267–1278. - PubMed
    1. Ren J, Grundy SM, Liu J, et al. Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese: the results of a 15-Year Chinese Multi-Provincial Cohort Study (CMCS) Atherosclerosis. 2010;211:327–332. - PubMed

LinkOut - more resources